| 瑞科生物-B |
招银国际金融控股有限公司 |
增持 |
22907700 |
2290.77万股 |
0.07% |
好仓 |
2023-02-20 |
| 承辉国际 |
Trident Trust Company (Singapore) Pte Limited |
减持 |
-9000000 |
22529.19万股 |
0.46% |
好仓 |
2023-02-20 |
| 瑞科生物-B |
招商银行股份有限公司 |
减持 |
-22907700 |
0.00万股 |
0.00% |
好仓 |
2023-02-20 |
| 瑞科生物-B |
招商银行股份有限公司 |
增持 |
22907700 |
2290.77万股 |
0.07% |
好仓 |
2023-02-20 |
| 瑞科生物-B |
Shenzhen Sequoia Huanyu Investment Consulting Co., Ltd. |
减持 |
-4480000 |
896.25万股 |
0.06% |
好仓 |
2023-02-20 |
| 瑞科生物-B |
Shenzhen Sequoia Antai Equity Investment Partnership (Limited Partnership) |
减持 |
-4480000 |
896.25万股 |
0.06% |
好仓 |
2023-02-20 |
| 瑞科生物-B |
Shenzhen Sequoia Yuchen Equity Investment Partnership (Limited Partnership) |
减持 |
-4480000 |
896.25万股 |
0.06% |
好仓 |
2023-02-20 |
| 瑞科生物-B |
Shenzhen Sequoia Yuechen Investment Partnership (Limited Partnership) |
减持 |
-4480000 |
896.25万股 |
0.06% |
好仓 |
2023-02-20 |
| 瑞科生物-B |
Shenzhen Sequoia Hanchen Equity Investment Partnership(L.P.) |
减持 |
-4480000 |
896.25万股 |
0.06% |
好仓 |
2023-02-20 |
| 泰凌医药 |
wang minzhi |
增持 |
463722859 |
46372.29万股 |
0.20% |
好仓 |
2023-02-20 |
| 永泰生物-B |
Tianjin Zhongzhi Technology Development Co., Ltd.* (天津众智科技发展有限公司) |
减持 |
-51480000 |
19159.57万股 |
0.37% |
好仓 |
2023-02-20 |
| 永泰生物-B |
Tianjin Tongming Technology Development Partnership (Limited Partnership)*(天津通明科技发展合伙企业(有限合伙)) |
减持 |
-51480000 |
19159.57万股 |
0.37% |
好仓 |
2023-02-20 |
| 永泰生物-B |
Tianjin Shunqi Technology Development Partnership (Limited Partnership)*(天津顺祺科技发展合伙企业(有限合伙)) |
减持 |
-51480000 |
19159.57万股 |
0.37% |
好仓 |
2023-02-20 |
| 永泰生物-B |
Tianjin Shanzhen Technology Development Partnership (Limited Partnership)*(天津善臻科技发展合伙企业(有限合伙)) |
减持 |
-51480000 |
19159.57万股 |
0.37% |
好仓 |
2023-02-20 |
| 永泰生物-B |
Tianjin Kangshun Technology Development Partnership (Limited Partnership)*(天津康顺科技发展合伙企业(有限合伙)) |
减持 |
-51480000 |
19159.57万股 |
0.37% |
好仓 |
2023-02-20 |
| 永泰生物-B |
Tianjin Hongxun Technology Development Partnership (Limited Partnership)*(天津鸿勋科技发展合伙企业(有限合伙)) |
减持 |
-51480000 |
19159.57万股 |
0.37% |
好仓 |
2023-02-20 |
| 永泰生物-B |
Tianjin Heyue Technology Development Partnership (Limited Partnership)*(天津和悦科技发展合伙企业(有限合伙)) |
减持 |
-51480000 |
19159.57万股 |
0.37% |
好仓 |
2023-02-20 |
| 永泰生物-B |
Tasly Pharmaceutical Group Co.,Ltd.* (天士力医药集团股份有限公司) |
减持 |
-51480000 |
19159.57万股 |
0.37% |
好仓 |
2023-02-20 |
| 永泰生物-B |
Tasly Holding Group Co., Ltd.* (天士力控股集团有限公司) |
减持 |
-51480000 |
19159.57万股 |
0.37% |
好仓 |
2023-02-20 |
| 永泰生物-B |
Tasly (Hong Kong) Pharmaceutical Investment Limited |
减持 |
-51480000 |
19159.57万股 |
0.37% |
好仓 |
2023-02-20 |
